跳至主要内容
临床试验/NCT02314455
NCT02314455终止不适用

Esophageal Absorption in Eosinophilic Esophagitis

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2014年9月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Mayo Clinic
入组人数
14
试验地点
2
主要终点
Reliability of the d-xylose testing defined by the serum levels

研究概览

简要总结

To determine how the esophagus in active and inactive stages of eosinophilic esophagitis tranmit fluids.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients between the ages of 18 and 80 with eosinophilic esophagitis diagnosed by a combination of compatible symptoms, endoscopic findings, histology, and lack of response to proton pump inhibitors or negative pH study
  • endoscopy with esophageal and duodenal biopsies within two weeks of performance of this study
  • Patients between the ages of 18 and 80 with eosinophilic esophagitis diagnosed by a combination of compatible symptoms, endoscopic findings, histology, and lack of response to proton pump inhibitors or negative pH study, and are now in histologic remission( <15phf) by the use of steroids or the six food elimination diet.
  • Volunteers will be selected for not having any history of esophageal symptoms

排除标准

  • Vulnerable populations, such as those with diminished mental acuity, will be excluded.
  • Patients taking Nsaids within 48 hours of the d-xylose testing
  • artificial sweeteners within 48 hours of the d-xylose testing
  • History of IBD
  • Currently smoking or history of smoking
  • History of Celiac disease
  • Bacterial overgrowth,
  • motility disorders
  • other diffuse small bowel diseases.

结局指标

主要结局

Reliability of the d-xylose testing defined by the serum levels

时间窗: 1 year

D-xylose serum levels will be drawn at 5 and 10 and 60 minutes. D-xylose levels will be compared between the patients with active EOE and healthy controls using the Wilcoxon rank sum test.

次要结局

  • D-xylose testing compared to endoscopy/biopsy findings.(1 year)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

David A. Katzka

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验

Esophageal Absorption in EoE | 临床试验